AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

(NASDAQ:NAGE) LOS ANGELES--(BUSINESS WIRE)---- $NAGE #AboutNAD--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today unveils the newly evolved AboutNADⓇ, a centralized educational resource and published research database detailing scientific advancements in NAD+ biology and its role in human health. Guided by the mission of empowering health through scientific education, the new and improved site distills peer-reviewed findin